The arsenal of therapies available to combat opioid addiction has expanded beyond pills and shots to include over-the-ear electrodes and virtual reality headsets. But an upcoming clinical trial could push the boundaries of addiction treatment further, and by a more invasive means than any therapy currently embraced by medical experts.

The therapy, called deep brain stimulation, requires electrodes to be implanted into the brain to regulate activity in the brain’s neurons, much like a pacemaker does to the heart. Deep brain stimulation is currently used to treat tremors related to Parkinson’s disease, and is being tested on patients diagnosed with a variety of brain disorders.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
Sign up to receive a free weekly opinions recap from our community of experts.
Privacy Policy